What is the current Influenza Medications Market size?

The Influenza Medications Market is projected to register a CAGR of 5.30% during the forecast period (2024-2029) Read More

Who are the key players in Influenza Medications Market?

Sanofi , GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd.(Genentech USA, Inc.), Seqirus and NATCO Pharma Limited are the major companies operating in the Influenza Medications Market. Read More

Which is the fastest growing region in Influenza Medications Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Influenza Medications Market?

In 2024, the North America accounts for the largest market share in Influenza Medications Market. Read More

What years does this Influenza Medications Market cover?

The report covers the Influenza Medications Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Influenza Medications Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Influenza Medications Market Share

Statistics for the 2023 & 2024 Influenza Medications market share, created by Mordor Intelligence™ Industry Reports. Influenza Medications share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Influenza Medications Industry

In Influenza Medications market major players are focused on expanding their business in different areas by adopting various market strategies such as partnerships, collaborations, acquisitions and mergers etc. Key developments in the market include US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Roche's XofluzaTM (baloxavir marboxil) for the Medications of acute, uncomplicated influenza, or flu in OCT 2019.